pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-KEN-2018-04101 | Kenya | 2,018 | Regional | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Not done | Positive | Negative | 70.1 | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-GHA-2023-04102 | Ghana | 2,023 | District | Breast | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Absent | Negative | Not done | Not done | Negative | 13.0 | Positive | HER2+ | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2021-04103 | Tanzania | 2,021 | District | Prostate | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | Not done | Not done | null | Core needle biopsy | No - inconclusive | 14 | moderate_burden |
PATH-ETH-2024-04104 | Ethiopia | 2,024 | District | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 69.8 | Positive | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-GHA-2018-04105 | Ghana | 2,018 | District | Cervix | 8310/3 | Clear cell carcinoma | Undifferentiated | Absent | Present | Negative | Positive | Positive | Negative | 47.6 | Negative | null | Fine needle aspirate | Yes | 10 | moderate_burden |
PATH-SOU-2024-04106 | South Africa | 2,024 | Regional | Colorectal | 8310/3 | Clear cell carcinoma | Poorly differentiated | Present | Not documented | Positive | Positive | Positive | Not done | 33.5 | Positive | null | Fine needle aspirate | Yes | 8 | moderate_burden |
PATH-NIG-2023-04107 | Nigeria | 2,023 | Regional | Prostate | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Absent | Close | Negative | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-KEN-2025-04108 | Kenya | 2,025 | District | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Negative | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-GHA-2019-04109 | Ghana | 2,019 | National referral | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Not applicable | Positive | Positive | Negative | 81.8 | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-KEN-2022-04110 | Kenya | 2,022 | Regional | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Not documented | Negative | Negative | Negative | Negative | 87.7 | Positive | null | Resection | Yes | 24 | moderate_burden |
PATH-TAN-2018-04111 | Tanzania | 2,018 | District | Bladder | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Positive | Positive | Negative | 53.8 | Positive | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-NIG-2023-04112 | Nigeria | 2,023 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Negative | Not done | 89.5 | Positive | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2023-04113 | Tanzania | 2,023 | National referral | Ovary | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Positive | Negative | 77.5 | Negative | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-KEN-2022-04114 | Kenya | 2,022 | Regional | Prostate | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Absent | Close | Not done | Positive | Negative | 37.2 | Not done | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-ETH-2019-04115 | Ethiopia | 2,019 | National referral | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Present | Close | Not done | Not done | Negative | 37.2 | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-TAN-2019-04116 | Tanzania | 2,019 | Regional | Stomach | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-UGA-2022-04117 | Uganda | 2,022 | District | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | Not done | Positive | Luminal B | Excisional biopsy | Yes | 14 | moderate_burden |
PATH-GHA-2024-04118 | Ghana | 2,024 | National referral | Ovary | 8140/3 | Adenocarcinoma | Well differentiated | Present | Absent | Negative | Positive | Negative | Negative | 47.5 | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-UGA-2022-04119 | Uganda | 2,022 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Close | Negative | Positive | Positive | 59.9 | Negative | null | Resection | Yes | 9 | moderate_burden |
PATH-ETH-2025-04120 | Ethiopia | 2,025 | District | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 9 | moderate_burden |
PATH-ETH-2022-04121 | Ethiopia | 2,022 | Regional | Prostate | 8140/3 | Adenocarcinoma | Well differentiated | Present | Absent | Close | Positive | Positive | Positive | 89.4 | Positive | null | Resection | Yes | 15 | moderate_burden |
PATH-ETH-2025-04122 | Ethiopia | 2,025 | National referral | Lung | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 45.4 | Positive | null | Fine needle aspirate | Yes | 22 | moderate_burden |
PATH-TAN-2025-04123 | Tanzania | 2,025 | Regional | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Close | Not done | Positive | Negative | 30.0 | Negative | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-TAN-2020-04124 | Tanzania | 2,020 | Regional | Stomach | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-NIG-2020-04125 | Nigeria | 2,020 | Regional | Prostate | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Absent | Absent | Close | Positive | Positive | Negative | 81.4 | Positive | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-NIG-2022-04126 | Nigeria | 2,022 | District | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Close | Positive | Negative | Not done | 63.9 | Negative | null | Resection | Yes | 11 | moderate_burden |
PATH-GHA-2018-04127 | Ghana | 2,018 | District | Liver | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Resection | Yes | 16 | moderate_burden |
PATH-TAN-2020-04128 | Tanzania | 2,020 | Regional | Liver | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | 50.1 | Negative | null | Core needle biopsy | No - inconclusive | 8 | moderate_burden |
PATH-NIG-2023-04129 | Nigeria | 2,023 | Regional | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Positive | Negative | Negative | Negative | 79.0 | Positive | null | Resection | Yes | 19 | moderate_burden |
PATH-GHA-2022-04130 | Ghana | 2,022 | Regional | Cervix | 8890/3 | Leiomyosarcoma | Well differentiated | Present | Absent | Negative | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-KEN-2023-04131 | Kenya | 2,023 | Regional | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Negative | Positive | Negative | Not done | Negative | null | Resection | Yes | 19 | moderate_burden |
PATH-SOU-2018-04132 | South Africa | 2,018 | National referral | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | 23.0 | Positive | Luminal B | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-GHA-2019-04133 | Ghana | 2,019 | District | Breast | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Positive | Negative | Positive | Not done | Positive | Luminal A | Resection | Yes | 4 | moderate_burden |
PATH-GHA-2025-04134 | Ghana | 2,025 | Regional | Bladder | 8430/3 | Mucoepidermoid carcinoma | Well differentiated | Present | Absent | Negative | Positive | Positive | Positive | 59.2 | Not done | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-GHA-2021-04135 | Ghana | 2,021 | District | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Not done | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-ETH-2023-04136 | Ethiopia | 2,023 | National referral | Liver | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Not applicable | Positive | Negative | Negative | Not done | Not done | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-TAN-2021-04137 | Tanzania | 2,021 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | 17.7 | Positive | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-ETH-2025-04138 | Ethiopia | 2,025 | District | Ovary | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Present | Negative | Positive | Negative | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 16 | moderate_burden |
PATH-KEN-2022-04139 | Kenya | 2,022 | District | Ovary | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Positive | Negative | Not done | Not done | null | Resection | Yes | 3 | moderate_burden |
PATH-KEN-2020-04140 | Kenya | 2,020 | National referral | Cervix | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-GHA-2025-04141 | Ghana | 2,025 | National referral | Cervix | 8070/3 | Squamous cell carcinoma | Undifferentiated | Not documented | Not documented | Close | Negative | Negative | Negative | 85.2 | Positive | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-GHA-2019-04142 | Ghana | 2,019 | Regional | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Positive | Negative | 78.0 | Negative | null | Resection | No - inconclusive | 10 | moderate_burden |
PATH-ETH-2021-04143 | Ethiopia | 2,021 | District | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Not done | Negative | Negative | Not done | Not done | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2022-04144 | Tanzania | 2,022 | District | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Not done | Not done | Not done | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-GHA-2018-04145 | Ghana | 2,018 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Not done | Negative | 84.8 | Positive | null | Fine needle aspirate | Yes | 10 | moderate_burden |
PATH-GHA-2022-04146 | Ghana | 2,022 | National referral | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Negative | Positive | 77.1 | Negative | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-UGA-2022-04147 | Uganda | 2,022 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Positive | Positive | Not done | Not done | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-NIG-2024-04148 | Nigeria | 2,024 | District | Liver | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Positive | Positive | 62.9 | Positive | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-ETH-2024-04149 | Ethiopia | 2,024 | National referral | Cervix | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | 30.8 | Negative | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-TAN-2024-04150 | Tanzania | 2,024 | Regional | Prostate | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Not done | Not done | Not done | Positive | null | Resection | Yes | 6 | moderate_burden |
PATH-KEN-2019-04151 | Kenya | 2,019 | District | Lung | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Positive | Not done | 69.6 | Negative | null | Resection | Yes | 4 | moderate_burden |
PATH-ETH-2023-04152 | Ethiopia | 2,023 | District | Stomach | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-UGA-2020-04153 | Uganda | 2,020 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Positive | Positive | Negative | 59.3 | Positive | null | Resection | Yes | 26 | moderate_burden |
PATH-SOU-2019-04154 | South Africa | 2,019 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Close | Positive | Positive | Negative | 22.6 | Negative | null | Resection | Yes | 20 | moderate_burden |
PATH-UGA-2023-04155 | Uganda | 2,023 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Negative | Negative | Negative | Equivocal | 18.9 | Positive | null | Fine needle aspirate | Yes | 23 | moderate_burden |
PATH-ETH-2021-04156 | Ethiopia | 2,021 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Positive | Negative | 71.2 | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-UGA-2018-04157 | Uganda | 2,018 | Regional | Thyroid | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Not done | 26.9 | Positive | null | Fine needle aspirate | Yes | 25 | moderate_burden |
PATH-ETH-2022-04158 | Ethiopia | 2,022 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | 47.5 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-SOU-2023-04159 | South Africa | 2,023 | District | Breast | 8310/3 | Clear cell carcinoma | Poorly differentiated | Present | Absent | Negative | Not done | Positive | Negative | 84.1 | Positive | Luminal A | Core needle biopsy | No - suboptimal | 25 | moderate_burden |
PATH-UGA-2022-04160 | Uganda | 2,022 | National referral | Prostate | 8890/3 | Leiomyosarcoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Equivocal | 59.7 | Positive | null | Resection | Yes | 14 | moderate_burden |
PATH-GHA-2023-04161 | Ghana | 2,023 | Regional | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Positive | 75.2 | Not done | Luminal B | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-ETH-2020-04162 | Ethiopia | 2,020 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Not applicable | Positive | Positive | Negative | 26.8 | Positive | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-KEN-2020-04163 | Kenya | 2,020 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Negative | null | Resection | Yes | 10 | moderate_burden |
PATH-TAN-2020-04164 | Tanzania | 2,020 | District | Breast | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Absent | Not applicable | Not done | Positive | Negative | Not done | Not done | Luminal A | Resection | Yes | 6 | moderate_burden |
PATH-ETH-2020-04165 | Ethiopia | 2,020 | Regional | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Close | Positive | Positive | Negative | 72.4 | Positive | null | Resection | Yes | 4 | moderate_burden |
PATH-GHA-2022-04166 | Ghana | 2,022 | District | Ovary | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Present | Absent | Close | Positive | Negative | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 10 | moderate_burden |
PATH-SOU-2025-04167 | South Africa | 2,025 | Regional | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Negative | Negative | 73.2 | Not done | null | Fine needle aspirate | Yes | 15 | moderate_burden |
PATH-KEN-2024-04168 | Kenya | 2,024 | District | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-UGA-2024-04169 | Uganda | 2,024 | National referral | Cervix | 8720/3 | Melanoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 37.1 | Negative | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-NIG-2021-04170 | Nigeria | 2,021 | National referral | Liver | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Positive | 33.9 | Not done | null | Excisional biopsy | Yes | 9 | moderate_burden |
PATH-ETH-2020-04171 | Ethiopia | 2,020 | Regional | Thyroid | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Present | Negative | Positive | Positive | Equivocal | 71.1 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-UGA-2024-04172 | Uganda | 2,024 | District | Thyroid | 8140/3 | Adenocarcinoma | Well differentiated | Not documented | Not documented | Positive | Positive | Positive | Negative | 16.9 | Negative | null | Resection | No - inconclusive | 23 | moderate_burden |
PATH-KEN-2020-04173 | Kenya | 2,020 | District | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Close | Positive | Positive | Negative | 36.4 | Negative | null | Resection | Yes | 19 | moderate_burden |
PATH-ETH-2019-04174 | Ethiopia | 2,019 | Regional | Cervix | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Negative | Positive | 11.7 | Negative | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-GHA-2022-04175 | Ghana | 2,022 | District | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Negative | Positive | Negative | Not done | Not done | null | Resection | Yes | 7 | moderate_burden |
PATH-SOU-2024-04176 | South Africa | 2,024 | District | Breast | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Positive | Positive | Negative | Not done | Negative | Luminal A | Resection | Yes | 18 | moderate_burden |
PATH-KEN-2023-04177 | Kenya | 2,023 | District | Breast | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Positive | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 10 | moderate_burden |
PATH-NIG-2018-04178 | Nigeria | 2,018 | District | Cervix | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Not done | Negative | 60.6 | Not done | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-SOU-2025-04179 | South Africa | 2,025 | Regional | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Present | Positive | Positive | Not done | Negative | 41.0 | Positive | Triple negative | Excisional biopsy | Yes | 17 | moderate_burden |
PATH-ETH-2025-04180 | Ethiopia | 2,025 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Positive | Negative | Positive | Negative | 32.0 | Positive | null | Fine needle aspirate | Yes | 17 | moderate_burden |
PATH-KEN-2024-04181 | Kenya | 2,024 | District | Bladder | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Close | Not done | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-SOU-2022-04182 | South Africa | 2,022 | District | Thyroid | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Positive | Not done | Not done | null | Resection | Yes | 19 | moderate_burden |
PATH-SOU-2019-04183 | South Africa | 2,019 | District | Stomach | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Negative | Positive | Not done | 17.1 | Not done | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-TAN-2022-04184 | Tanzania | 2,022 | District | Stomach | 8260/3 | Papillary carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Positive | Positive | Not done | Positive | null | Resection | Yes | 26 | moderate_burden |
PATH-KEN-2019-04185 | Kenya | 2,019 | National referral | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | 77.9 | Positive | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-TAN-2024-04186 | Tanzania | 2,024 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Not documented | Positive | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-TAN-2019-04187 | Tanzania | 2,019 | District | Stomach | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Absent | Negative | Positive | Positive | Negative | 57.5 | Negative | null | Resection | No - inconclusive | 25 | moderate_burden |
PATH-GHA-2024-04188 | Ghana | 2,024 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Not done | 49.2 | Positive | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-SOU-2025-04189 | South Africa | 2,025 | District | Thyroid | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Negative | Positive | Not done | Negative | Not done | Positive | null | Resection | Yes | 15 | moderate_burden |
PATH-ETH-2020-04190 | Ethiopia | 2,020 | National referral | Colorectal | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Positive | 37.7 | Not done | null | Resection | Yes | 24 | moderate_burden |
PATH-KEN-2020-04191 | Kenya | 2,020 | District | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Negative | Positive | 25.5 | Positive | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-KEN-2022-04192 | Kenya | 2,022 | Regional | Lung | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 10 | moderate_burden |
PATH-ETH-2024-04193 | Ethiopia | 2,024 | District | Thyroid | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Not documented | Close | Not done | Negative | Negative | Not done | Positive | null | Resection | Yes | 16 | moderate_burden |
PATH-SOU-2024-04194 | South Africa | 2,024 | District | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Close | Negative | Positive | Negative | Not done | Positive | null | Resection | Yes | 19 | moderate_burden |
PATH-UGA-2021-04195 | Uganda | 2,021 | District | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Positive | Not done | Not done | Positive | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-TAN-2022-04196 | Tanzania | 2,022 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Close | Positive | Positive | Negative | 36.6 | Positive | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-GHA-2024-04197 | Ghana | 2,024 | District | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Negative | Negative | Not done | Not done | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-GHA-2023-04198 | Ghana | 2,023 | National referral | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Not applicable | Positive | Negative | Negative | 76.7 | Not done | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2023-04199 | Tanzania | 2,023 | District | Prostate | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Present | Close | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | No - inconclusive | 12 | moderate_burden |
PATH-TAN-2019-04200 | Tanzania | 2,019 | Regional | Breast | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Not done | Not done | Negative | HER2+ | Core needle biopsy | Yes | 25 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.